Placental exosomes and pre-eclampsia: Maternal circulating levels in normal pregnancies and, early and late onset pre-eclamptic pregnancies

Placenta

Volumn 46, Issue , 2016, Pages 18-25

  Pillay, Preenan ^a   Maharaj, Niren ^d   Moodley, Jagidesa ^c   Mackraj, Irene ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d Prince Mshiyeni Memorial Hospital   (South Africa)

Author keywords

Early onset preeclampsia; Exosomes; Late onset pre eclampsia; Placental derived exosomes

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; NANOPARTICLE;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; DISEASE COURSE; EXOSOME; FEMALE; HUMAN; LATE ONSET DISORDER; MATERNAL PLASMA; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; ULTRACENTRIFUGATION; BLOOD; CASE CONTROL STUDY; PLACENTA; SECRETION (PROCESS); YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; EXOSOMES; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 84983801491     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2016.08.078     Document Type: Article

References (38)

1. [1] Tranquilli, A.I., Dekker, G., Magee, L., Roberts, J., Sibai, B.M., Steyn, W., Zeeman, G.G., Brown, M.A., International society for the study of hypertension in pregnancy, the classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 4 (2014), 97–104.
2. [2] Lana, K., Wagner, M.D., Diagnosis and management of pre-eclampsia. Am. Fam. Physician 70 (2004), 2317–2324.
3. [3] Kuklina, E., Ayala, C., Callaghan, W., Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynaecol. 113 (2009), 1299–1306.
4. [4] Lisonkova, S., Joseph, K.S., Incidence of Pre-eclampsia: risk factors and outcomes associated with early vs late onset disease. Am. J. Obstet. Gynaecol. 209 (2013), 1–12.
5. [5] Raymond, D., Peterson, E., A critical review of early-onset and late-onset pre-eclampsia. Obstet Gynaecol Surv 66 (2011), 497–506.
6. [6] Huppertz, B., Placental origins of pre-eclampsia. Hypertension 51 (2008), 970–975.
7. [7] Redman, C.W.G., The six stages of pre-eclampsia. Pregnancy Hypertens. 4:3 (2014), 241–247.
8. [8] Tannetta, D., Sargent, I.L., Placental disease and the maternal syndrome of pre-eclampsia: missing links?. Curr. Hypertens. Rep. 15 (2013), 590–599.
9. [9] Powe, C.E., Levine, R.J., Karumanchi, A., Pre-eclampsia a disease of the maternal endothelium: role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation 123:24 (2011), 2856–2869.
10. [10] Dechend, R., F.C Luft, Angiogenesis factors and pre-eclampsia. Nat. Med. 14 (2008), 1187–1188.
11. [11] Bartha, J.L., Del-Fresno, P.M., Comino, R.C., Gestational diabetes mellitus diagnosed during early pregnancy. Am. J. Obstet. Gynaecol. 182:2 (2000), 346–350.
12. [12] Lukke, J.A., Roos, J.L., Sibai, B.M., Funai, E.F., Triche, E.W., Paidas, M.J., Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 53 (2009), 944–951.
13. [13] Salvianti, F., Inversetti, A., Smid, M., Valsecchi, L., Candiani, M., Pazzagli, M., Cremonesi, L., Ferrari, M., Pinzani, P., Galbiati, S., Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia. Placenta 36:9 (2015), 996–1001.
14. [14] Verlohren, S., Galindo, A., Schlembach, D., Zeisler, H., Herraiz, I., Moertl, M.G., Pape, J., Dudenhausen, J.W., Denk, B., Stepan, H., An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol., 202(2), 2010 (2):161 e161-161 e111.
15. [15] Verlohren, S., Stepan, H., Dechend, R., Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin. Sci. Lond. 112 (2012), 43–52.
16. [16] Redman, C.W.G., Sargent, I.L., Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol. 76 (2007), 61–67.
17. [17] Redman, C.W.G., Sargent, I.L., Placental debris, oxidative stress and pre-eclampsia. Placenta 21:7 (2000), 597–602.
18. [18] Sargent, I.L., Germain, S.L., Sacks, G.P., Kumar, S., Redman, C.W.G., Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J. Reprod. Immunol. 59 (2003), 153–160.
19. [19] Redman, C.W.G., Tannetta, D.S., Dragovic, R.A., Gardiner, C., Southcombe, J.H., Collett, G.P., Sargent, I.L., Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 33 (2012), 48–54.
20. [20] Taylor, D.D., Akyol, S., Gercel-Taylor, C., Pregnancy-associated exosomes and their modulation of T cell signalling. J. Immunol. 176:3 (2006), 1534–1542.
21. [21] Sabapatha, A., Gercel-Taylor, C., Taylor, D.D., Specific isolation of placental-derived exosomes from the circulation of pregnant woman and their immunoregularory consequences. Am. J. Reprod. Immunol. 56 (2006), 345–355.
22. [22] Mincheva-Nilsson, L., Baranov, V., Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success. Am. J. Reprod. Immunol. 72:5 (2014), 440–457.
23. [23] Mitchell, M.D., Peiris, H.N., Kobayashi, M., Koh, Y.Q., Duncombe, G., Illanes, S.E., Rice, G.E., Salomon, S., Placental exosomes in normal and complicated pregnancies. Am. J. Obstet. Gynaecol. 4 (2015), S173–S181.
24. [24] Zhang, L., Valencia, C.A., Dong, B., Chen, M., Guan, P.J., Pan, L., Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J. Haematol. Oncol. 8 (2015), 14–18.
25. [25] Robbins, P.D., Morelli, A.E., Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 3 (2014), 195–208.
26. [26] Denzer, K., Kleijmeer, M.J., Heijnen, H.F., Stoorvogel, W., Geuze, H.J., Exosome: from internal vesicle of the multivesicular body to intercellular signalling device. J. Cell Sci. 113 (2000), 3365–3374.
27. [27] Salomon, C., Torres, M.J., Kobayashi, M., Scholz-Romero, K., Sobrevia, L., Dobierzewska, A., Illanes, S.E., Mitchell, M.D., Rice, G.E., A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration. PLoS ONE, 9, 2014 9e:e98667.
28. [28] Sarker, S., Scholz-Romero, K., Perez, A., Illanes, S.E., Mitchell, M.D., Rice, G.E., Salomon, C., Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. J. Transl. Med., 12, 2014.
29. [29] Mathivanan, S., Ji, H., Simpson, R.J., Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73 (2010), 1907–1920.
30. [30] Salomon, C., Ryan, J., Sobrevia, L., Kobayashi, M., Ashman, K., Mitchell, M., Rice, G.E., Exosome Signalling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS ONE, 8, 2013.
31. [31] Dragovic, R.A., Collett, G.P., Hole, P., Ferguson, D.J.P., Redman, C.W., Sargent, I.L., Tannetta, D.S., Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence nanoparticle tracking analysis. Methods 87 (2015), 64–74.
32. [32] Théry, C., Amigorena, S., Raposo, G., Clayton, A., Isolation of exosomes from cell culture supernatants and biological fluids. Bonifacino, J.S., (eds.) Curr Protoc Cell Bio, 2006, 3.22.1–3.22.29.
33. [33] Crispi, F., Illurba, E., Inguez, C.D., Gallan, P.M., Cabero, L., Gratacos, E., Predictive value of angiogenic factors & utery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet. Gynaecol. 31 (2008), 303–309.
34. [34] D'Anna, R., Baviera, G., Corrado, F., Giordano, D., De Vivo, A., Nicocia, G., Di Benedetto, A., Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 113 (2006), 1264–1269.
35. [35] Roberts, J.M., Gammill, H.S., Preeclampsia: recent insights. Hypertension 46 (2005), 1243–1249.
36. [36] Barry, B., Serum heat-stable alkaline phosphatase in pregnancy complicated by hypertension. J. Obstetrics Gynecol. Br. Commonw. 77 (1970), 990–993 77.
37. [37] Hunter, R.J., Herret, J.D., Serum heat-stable alkaline phosphatase levels in normal and abnormal pregnancies. J. Obstetrics Gynecol. Br. Commonw. 70 (1973), 957–961.
38. [38] Sussman, H.H., Bowman, M., Placental alkaline phosphatase in maternal serum during normal and abnormal pregnancy. Nature 218 (1968), 359–360.